Filed with ASX · · 35 pages · English
Neurizon Therapeutics Limited has issued a notice for its upcoming Annual General Meeting scheduled for late November. The meeting will be held as a hybrid event, allowing shareholders to participate either in person or online. The agenda includes the adoption of the remuneration report and the election of a new director, among other resolutions. Shareholders are encouraged to submit their proxies ahead of the meeting to ensure their votes are counted.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Neurizon Therapeutics Limited ABN 35 094 006 023 www.neurizon.com 26 October 2026 Dear Shareholder, Neurizon Therapeutics Limited – Annual General Meeting of Shareholders – 25 November 2026 Notice is hereby given that the Annual General Meeting of Shareholders of Neurizon Therapeutics Limited...
Neurizon Therapeutics Limited on 6ix
Follow Neurizon Therapeutics into a list and get an email when it puts out news.
Follow Neurizon Therapeutics